Phosphatidylcholine-DHA biosynthesis and neural membrane assembly

Phosphatidylcholine-DHA biosynthesis and neural membrane assembly refers to the integrated metabolic sequence responsible for producing the structural lipids necessary for neuronal synapses (Wurtman et al., 2009). This process is primarily driven by the Kennedy pathway, which utilizes rate-limiting precursors such as choline, uridine (converted to CTP), and omega-3 fatty acids like docosahexaenoic acid (DHA) to synthesize phosphatidylcholine (Kennedy & Weiss, 1956). These DHA-enriched phospholipids are essential for maintaining membrane fluidity, supporting the docking of synaptic vesicles, and facilitating signal transduction (Cansev, 2006). In neurodegenerative conditions like Alzheimer's disease, a significant reduction in these membrane phosphatides is observed, contributing to synaptic loss and cognitive decline (Wurtman, 2014). Therapeutic interventions, most notably the medical food Fortasyn Connect (Souvenaid), target this process by providing the necessary building blocks to stimulate endogenous synaptogenesis (Shah et al., 2013). By enhancing the structural integrity of neuronal membranes, this approach aims to preserve connectivity and slow cognitive deterioration in early-stage dementia.

Other names

Kennedy pathwayCDP-choline pathwayPhospholipid biosynthesisSynaptogenesis pathway

Upregulation of the Kennedy (CDP-choline) pathway via the provision of rate-limiting precursors to increase the synthesis of synaptic membrane phospholipids.